Putcha, D., Katsumi, Y., Touroutoglou, A., Eloyan, A., Taurone, A., Thangarajah, M., Aisen, P., Dage, J. L., Foroud, T., Jack, C. R., Kramer, J. H., Nudelman, K. N. H., Raman, R., Vemuri, P., Atri, A., Day, G. S., Duara, R., Graff-Radford, N. R., Grant, I. M., … Honig, L. S. (2025). Heterogeneous clinical phenotypes of sporadic early-onset Alzheimer’s disease: a neuropsychological data-driven approach. Alzheimer’s Research & Therapy, 17(1). https://doi.org/10.1186/s13195-025-01689-8

Pandey, N., Yang, Z., Cieza, B., Reyes-Dumeyer, D., Kang, M. S., Montesinos, R., Soto-Añari, M., Custodio, N., Honig, L. S., & Tosto, G. (2025). Plasma phospho-tau217 as a predictive biomarker for Alzheimer’s disease in a large south American cohort. Alzheimer’s Research & Therapy, 17(1). https://doi.org/10.1186/s13195-024-01655-w

Honig, L. S., Sabbagh, M. N., van Dyck, C. H., Sperling, R. A., Hersch, S., Matta, A., Giorgi, L., Gee, M., Kanekiyo, M., Li, D., Purcell, D., Dhadda, S., Irizarry, M., & Kramer, L. (2024). Updated safety results from phase 3 lecanemab study in early Alzheimer’s disease. Alzheimer’s Research & Therapy, 16(1). https://doi.org/10.1186/s13195-024-01441-8

Morales, C. D., Cotton-Samuel, D., Lao, P. J., Chang, J. F., Pyne, J. D., Alshikho, M. J., Lippert, R. V., Bista, K., Hale, C., Edwards, N. C., Igwe, K. C., Deters, K., Zimmerman, M. E., & Brickman, A. M. (2024). Small vessel cerebrovascular disease is associated with cognition in prospective Alzheimer’s clinical trial participants. Alzheimer’s Research & Therapy, 16(1). https://doi.org/10.1186/s13195-024-01395-x

Barbera, M., Lehtisalo, J., Perera, D., Aspö, M., Cross, M., De Jager Loots, C. A., Falaschetti, E., Friel, N., Luchsinger, J. A., Gavelin, H. M., Peltonen, M., Price, G., Neely, A. S., Thunborg, C., Tuomilehto, J., Mangialasche, F., Middleton, L., Ngandu, T., … Solomon, A. (2024). A multimodal precision-prevention approach combining lifestyle intervention with metformin repurposing to prevent cognitive impairment and disability: the MET-FINGER randomised controlled trial protocol. Alzheimer’s Research & Therapy, 16(1). https://doi.org/10.1186/s13195-023-01355-x

Mei, H., Simino, J., Li, L., Jiang, F., Bis, J. C., Davies, G., Hill, W. D., Xia, C., Gudnason, V., Yang, Q., Lahti, J., Smith, J. A., Kirin, M., De Jager, P., Armstrong, N. J., Ghanbari, M., Kolcic, I., Moran, C., Teumer, A., … Mosley, T. H. (2024). Multi-omics and pathway analyses of genome-wide associations implicate regulation and immunity in verbal declarative memory performance. Alzheimer’s Research & Therapy, 16(1). https://doi.org/10.1186/s13195-023-01376-6

Katayama, O., Stern, Y., Habeck, C., Lee, S., Harada, K., Makino, K., Tomida, K., Morikawa, M., Yamaguchi, R., Nishijima, C., Misu, Y., Fujii, K., Kodama, T., & Shimada, H. (2023). Neurophysiological markers in community-dwelling older adults with mild cognitive impairment: an EEG study. Alzheimer’s Research & Therapy, 15(1). https://doi.org/10.1186/s13195-023-01368-6

Javitt, D. C., Martinez, A., Sehatpour, P., Beloborodova, A., Habeck, C., Gazes, Y., Bermudez, D., Razlighi, Q. R., Devanand, D. P., & Stern, Y. (2023). Disruption of early visual processing in amyloid-positive healthy individuals and mild cognitive impairment. Alzheimer’s Research & Therapy, 15(1). https://doi.org/10.1186/s13195-023-01189-7

Schoemaker, D., Zanon Zotin, M. C., Chen, K., Igwe, K. C., Vila-Castelar, C., Martinez, J., Baena, A., Fox-Fuller, J. T., Lopera, F., Reiman, E. M., Brickman, A. M., & Quiroz, Y. T. (2022). White matter hyperintensities are a prominent feature of autosomal dominant Alzheimer’s disease that emerge prior to dementia. Alzheimer’s Research & Therapy, 14(1). https://doi.org/10.1186/s13195-022-01030-7

Feng, X., Provenzano, F. A., & Small, S. A. (2022). A deep learning MRI approach outperforms other biomarkers of prodromal Alzheimer’s disease. Alzheimer’s Research & Therapy, 14(1). https://doi.org/10.1186/s13195-022-00985-x

Goldman, J. G., Boeve, B. F., Armstrong, M. J., Galasko, D. R., Galvin, J. E., Irwin, D. J., Leverenz, J. B., Marder, K., Abler, V., Biglan, K., Irizarry, M. C., Keller, B., Lai, R., Munsie, L., Belleville, M., Chaney, O., Richard, I., Taylor, A., & Graham, T. (2021). Lewy Body Dementia Association’s Industry Advisory Council: proceedings of the second annual meeting. Alzheimer’s Research & Therapy, 13(1). https://doi.org/10.1186/s13195-021-00868-7

Boyle, R., Knight, S. P., De Looze, C., Carey, D., Scarlett, S., Stern, Y., Robertson, I. H., Kenny, R. A., & Whelan, R. (2021). Verbal intelligence is a more robust cross-sectional measure of cognitive reserve than level of education in healthy older adults. Alzheimer’s Research & Therapy, 13(1). https://doi.org/10.1186/s13195-021-00870-z